Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | GCGR | P47871 | 2/20 | 0.36 |
| ▸ | GIPR | P48546 | 2/20 | 0.36 |
| ▸ | GLP1R | P43220 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 2/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30930310 | 0.90 | MCHR1 (0.39) | NPSR1MAPTTP53POLBTHRB | |
| SCHEMBL30930414 | 0.88 | MAPT (0.47) | NPSR1MAPTTP53POLBMCHR1 | |
| SCHEMBL30930375 | 0.87 | CYP2D6 (0.39) | NPSR1MAPTTP53THRBMCHR1 | |
| SCHEMBL30930376 | 0.86 | MAPT (0.47) | NPSR1MAPTTP53POLBMCHR1 | |
| SCHEMBL30930458 | 0.85 | MAPT (0.43) | NPSR1MAPTTP53THRBCYP2D6 | |
| SCHEMBL30930472 | 0.85 | CYP2D6 (0.39) | NPSR1MAPTTDP1TP53THRB | |
| SCHEMBL30930515 | 0.85 | KDM4E (0.42) | NPSR1MAPTTP53THRBCYP2D6 | |
| SCHEMBL30930352 | 0.85 | MAPK1 (0.40) | NPSR1MAPTTP53THRBMCHR1 | |
| SCHEMBL30930355 | 0.85 | MAPT (0.42) | NPSR1MAPTTP53POLBTHRB | |
| SCHEMBL30930428 | 0.84 | MEN1 (0.38) | NPSR1MAPTTP53THRBMCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103363-A | Novel capsid assembly inhibitor | 南韩商AM科学股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| US-20250009742-A1 | NOVEL CAPSID ASSEMBLY INHIBITORS | META-IMMUNE, INC. (KR) | 2025-01-09 | — | — | US | disclosed |
| CN-118103363-A | Novel capsid assembly inhibitor | 南韩商AM科学股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250009742-A1 | NOVEL CAPSID ASSEMBLY INHIBITORS | ZC3HAV1, ZC3HAV1L, MAVS | NPSR1 4581/4885MAPT 474/4885TDP1 1195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.